Stonebridge Financial Group »

Vertex Pharmaceuticals Incorporated shares owned by Stonebridge Financial Group

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Stonebridge Financial Group from 13F filings

Historical chart of Stonebridge Financial Group investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Stonebridge Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Stonebridge Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $215k 433 496.73
2025-03-31 $201k 415 484.82
2024-12-31 $165k 410 402.70

More positions owned by Stonebridge Financial Group

Ishares Tr Core Div Grwth (DGRO)
Pimco Etf Tr Shtrm Mun Bd Act (SMMU)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)
Victory Portfolios Ii Short Trm Bd Etf (USTB)
Invesco Exchange Traded Fd T Rafi Us 1500 (PRFZ)
Pimco Etf Tr Multisector Bd (PYLD)
Apple (AAPL)
Pimco Etf Tr Inter Mun Bd Act (MUNI)
Select Sector Spdr Tr St Str Indl Etf (XLI)
Ishares Core Msci Emkt (IEMG)
Select Sector Spdr Tr St Str Techn Etf (XLK)
Select Sector Spdr Tr St Str Finl Etf (XLF)
Vanguard Intl Equity Index F Ftse Pacific Etf (VPL)
Spdr Series Trust ST STR P500GRW (SPYG)
Wisdomtree Tr Floatng Rat Trea (USFR)

View all positions for Stonebridge Financial Group

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Alliancebernstein
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas
Bank of America Corporation
Jennison Associates

View all funds holding Vertex Pharmaceuticals Incorporated